المؤلفون: Félix Couture, M Karamouzis, PL Etienne, Ian Chau, N Boku, M. Li, E Hitre, M Schenker, A Adenis, JS Aucoin, Kynan Tadao Feeney, M Möhler, Fabio Franke, Yelena Y. Janjigian, Jaffer A. Ajani, James M. Cleary, Guillermo Mendez

المصدر: 72. Jahrestagung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten mit Sektion Endoskopie – 11. Herbsttagung der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie gemeinsam mit den Arbeitsgemeinschaften der DGAV.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8fa77d0579d06d595804308c6e864277
https://doi.org/10.1055/s-0037-1604773

المؤلفون: Pl, Etienne, Jean-Luc Raoul, Jf, Bretagne, Mp, Ramee, Malier F, Gosselin M

المصدر: Europe PubMed Central

مصطلحات موضوعية: Radiography, Duodenal Neoplasms, Humans, Endoscopy, Female, Duodenal Diseases, Middle Aged, Intussusception, Neurilemmoma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bc267b1ec02146ce9b92152205c17504
https://pubmed.ncbi.nlm.nih.gov/2397868

المؤلفون: Pl, Etienne, Baffet G, Beatrice Desvergne, Boisnard-Rissel M, Glaise D, Guguen-Guillouzo C

المصدر: Europe PubMed Central

مصطلحات موضوعية: Male, Transcription, Genetic, Rats, Inbred Strains, Cell Communication, Rats, Proto-Oncogene Proteins c-myc, Gene Expression Regulation, Liver, Proto-Oncogene Proteins, Dactinomycin, Animals, RNA, Messenger, Cycloheximide, Proto-Oncogene Proteins c-fos, Cells, Cultured

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::53ccf4867e0fca3b8084fd4fb7ed6fd8
https://pubmed.ncbi.nlm.nih.gov/3144696

المؤلفون: laurent Siproudhis, Lescouarc'h J, Jf, Bretagne, Bourguet P, Jl, Raoul, Pl, Etienne, Jy, Herry, Gosselin M

المصدر: Europe PubMed Central

مصطلحات موضوعية: Male, Jejunal Neoplasms, Iodobenzenes, Rectal Neoplasms, Liver Neoplasms, Antineoplastic Agents, Carcinoid Tumor, Middle Aged, Mediastinal Neoplasms, Ileal Neoplasms, Iodine Radioisotopes, 3-Iodobenzylguanidine, Lymphatic Metastasis, Humans, Female, Prospective Studies, Radionuclide Imaging

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5a6bddf4953d83a2a4c5759bdc9be343
http://europepmc.org/abstract/med/1769467

المؤلفون: Conroy T; Institut de Cancérologie de Lorraine and INSERM, INSPIIRE, Université de Lorraine, Nancy. Electronic address: t.conroy@nancy.unicancer.fr., Castan F; Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier., Etienne PL; CARIO, Hôpital Privé des côtes d'Armor, Plérin., Rio E; Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint-Herblain., Mesgouez-Nebout N; Institut de Cancérologie de l'Ouest-Site Paul Papin, Angers., Evesque L; Centre Antoine Lacassagne, Nice., Vendrely V; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac., Artignan X; Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire., Bouché O; CHU Reims, Université de Reims Champagne-Ardenne, Reims., Gargot D; Centre Hospitalier de Blois, Blois., Boige V; Gustave Roussy, Villejuif., Bonichon-Lamichhane N; Clinique Tivoli, Bordeaux., Louvet C; Institut Mutualiste Montsouris, Paris., Morand C; Centre Hospitalier Départemental Vendée, site de la Roche-sur-Yon, La Roche-sur-Yon., de la Fouchardière C; Centre Léon Bérard, Lyon., Boilève A; Gustave Roussy, Villejuif., Delaye M; Institut Curie, Saint-Cloud., Gourgou S; Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier., Pezzella V; R&D Unicancer, Paris., Borg C; University Hospital of Besançon, CIC-BT1431, Besançon, France.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Oct; Vol. 35 (10), pp. 873-881. Date of Electronic Publication: 2024 Jul 08.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Rectal Neoplasms*/therapy , Rectal Neoplasms*/pathology , Rectal Neoplasms*/mortality , Neoadjuvant Therapy*/methods , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Adult ; Fluorouracil/administration & dosage ; Disease-Free Survival ; Chemoradiotherapy/methods ; Adenocarcinoma/therapy ; Adenocarcinoma/pathology ; Leucovorin/administration & dosage ; Leucovorin/therapeutic use ; Irinotecan/administration & dosage ; Irinotecan/therapeutic use ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Chemotherapy, Adjuvant/methods ; Oxaliplatin/administration & dosage ; Oxaliplatin/therapeutic use ; Camptothecin/analogs & derivatives ; Camptothecin/administration & dosage ; Camptothecin/therapeutic use

المؤلفون: Vendrely V; Radiation Oncology Department, CHU Bordeaux, Bordeaux, France; BRIC (BoRdeaux Institute of OnCology), UMR1312, INSERM, University of Bordeaux, F-33000 Bordeaux, France. Electronic address: veronique.vendrely@chu-bordeaux.fr., Ronchin P; Radiotherapy Department, Azuréen Cancer Center, Mougins, France., Minsat M; Radiation Oncology, Institut Curie, Paris, France., Le Malicot K; Fédération Francophone de Cancérologie Digestive, University of Burgundy, Biostatistics, Dijon, France, EPICAD INSERM LNC-UMR 1231, Dijon, France., Lemanski C; Department of Radiation Oncology, Montpellier Cancer Institute (ICM), Montpellier, France., Mirabel X; Radiotherapy Department, Centre Oscar Lambret, Lille, France., Etienne PL; Oncology Department, Centre CARIO-HPCA, Plerin, France., Lièvre A; Gastroenterology Department, Rennes University Hospital, Rennes 1 University, Inserm U1242 COSS (Chemistry Oncogenesis Stress Signaling), Rennes, France., Darut-Jouve A; Institut de cancérologie de Bourgogne GRReCC, Dijon, France., de la Fouchardière C; Oncology Department, Centre Léon Bérard, Lyon, France., Giraud N; Radiation Oncology Department, CHU Bordeaux, Bordeaux, France., Breysacher G; Oncology Department, Hôpitaux civils de Colmar, Colmar, France., Argo-Leignel D; Radiotherapy and Oncology Department, CHBS-Hôpital du Scorff, Lorient, France., Thimonnier E; Radiotherapy Department, Annecy Genevois, Pringy, France., Magné N; Radiotherapy and Oncology Department, Institut de Cancérologie Lucien Neuwirth, Saint Priest en Jarez, France., Abdelghani MB; Oncology Department, Centre Paul Strauss, Strasbourg, France., Lepage C; Department of Hepato-gastroenterology, University Hospital of Dijon, Dijon, France., Aparicio T; Gastroenterology and Digestive Oncology Department, Saint Louis Hospital, AP-HP, Paris, France.

مؤلفون مشاركون: for FFCD investigators/Collaborators

المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Sep; Vol. 186, pp. 109742. Date of Electronic Publication: 2023 Jun 12.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Anal Canal* , Anus Neoplasms*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Panitumumab/adverse effects ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; Fluorouracil/adverse effects ; Mitomycin/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin

SCR Disease Name: Anal Canal Carcinoma

المؤلفون: Bascoul-Mollevi C; Biometrics Unit, Institut du Cancer Montpellier, Montpellier, France; Institut Desbrest d'Epidémiologie et de Santé Publique, Université de Montpellier, Inserm, Montpellier, France; French National Platform Quality of Life and Cancer, France. Electronic address: caroline.mollevi@chu-montpellier.fr., Gourgou S; Biometrics Unit, Institut du Cancer Montpellier, Montpellier, France; French National Platform Quality of Life and Cancer, France., Borg C; University Hospital of Besançon, CIC-BT1431, Besançon, France., Etienne PL; CARIO, Hôpital Privé des côtes d'Armor, Plérin, France., Rio E; Institut de Cancérologie de l'Ouest - Site René Gauducheau, Saint-Herblain, France., Rullier E; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France., Juzyna B; R&D Unicancer, Paris, France., Castan F; Biometrics Unit, Institut du Cancer Montpellier, Montpellier, France; French National Platform Quality of Life and Cancer, France., Conroy T; Medical Oncology Department, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France; Université de Lorraine, APEMAC, Equipe MICS, Nancy, France.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Jun; Vol. 186, pp. 151-165. Date of Electronic Publication: 2023 Mar 24.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/pathology , Rectal Neoplasms*/pathology, Humans ; Male ; Irinotecan/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Oxaliplatin ; Leucovorin ; Quality of Life ; Neoadjuvant Therapy/methods ; Treatment Outcome ; Fluorouracil ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; Vomiting/chemically induced ; Neoplasm Staging

المؤلفون: Aparicio T; Gastroenterology and Digestive Oncology department, CHU Saint Louis, APHP, Université de Paris Cité, Paris, France. Electronic address: thomas.aparicio@aphp.fr., Bouché O; Gastroenterology and Digestive Oncology department, Reims, France., Etienne PL; Centre Armoricain de Radiothérapie, Imagerie, Oncologie, et Hôpital Privé des Côtes d'Armor, Plérin, France., Barbier E; Biostatistic department, Burgundy University, INSERM U866, Fédération Francophone de Cancérologie Digestive, Dijon, France., Mineur L; Oncology department, Clinique Saint Catherine, Avignon, France., Desgrippes R; Hepatogastroenterology and Digestive Oncology department, CH Saint-Malo, Saint-Malo, France., Guérin-Meyer V; Medical Oncology department, Institut Cancérologique de l'Ouest, Angers, France., Hocine F; CH Beauvais, Beauvais, France., Martin J; Oncology department, Clinique François Chenieux, Limoges, France., Le Brun-Ly V; Oncology department, CHU Dupuytren, Limoges, France., Cretin J; Oncogard, Alès, France., Desramé J; Oncology department, Hôpital Jean Mermoz, Lyon, France., Rinaldi Y; Hepato Gastroenterology department, Hôpital Européen de Marseille, Marseille, France., Cany L; Radiotherapy and Oncology department, Polyclinique Francheville, Perigueux, France., Falandry C; Geriatry department CHU Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France; Laboratoire CarMeN de l'Université de Lyon, Inserm U1060, INRA U1397, Université Claude Bernard Lyon 1, INSA Lyon, UCOGIR- Auvergne-Rhône-Alpes Ouest - Guyane., Lefevre LB; Oncology department, Centre Georges François Leclerc, Dijon, France., Marous M; CH Fort de France, Fort de France, France., Terrebonne E; Gastroenterology department, CHU Haut Lévèque, Pessac, France., Mosser L; Centre Hospitalier Jacques Puel, Rodez, France., Turpin J; CH Abbeville, Abbeville, France., Turpin A; Medical Oncology Department, CHU Lille, Lille, France., Bauguion L; CH La Roche sur Yon, La Roche sur Yon, France., Reichling C; CH Colmar, Colmar, France., Van den Eynde M; Gastroenterology and Digestive Oncology department, Cliniques Universitaires Saint Luc, Bruxelles, Belgium., Carola E; CH Creil, Creil, Paris, France., Hiret S; Medical Oncology department, Institut Cancérologique de l'Ouest, Saint Herblain, France.

المصدر: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2023 Apr; Vol. 55 (4), pp. 541-548. Date of Electronic Publication: 2022 Sep 14.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3562 (Electronic) Linking ISSN: 15908658 NLM ISO Abbreviation: Dig Liver Dis Subsets: MEDLINE

مواضيع طبية MeSH: Colonic Neoplasms*/drug therapy , Colonic Neoplasms*/surgery , Colonic Neoplasms*/pathology , Adenocarcinoma*/drug therapy , Adenocarcinoma*/surgery , Adenocarcinoma*/etiology , Frailty*, Humans ; Aged ; Oxaliplatin/therapeutic use ; Fluorouracil/therapeutic use ; Capecitabine/adverse effects ; Disease-Free Survival ; Chemotherapy, Adjuvant/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Staging ; Leucovorin/therapeutic use

المؤلفون: Legoux JL; Department of Hepato-Gastroenterology and Digestive Oncology, Hôpital de la Source, Orléans, France. Electronic address: jl.legoux@wanadoo.fr., Lombard-Bohas C; Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France., Brixi H; Department of Hepato-Gastroenterology, Hôpital Robert Debré, Reims, France., Le Malicot K; Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France., Lecomte T; Department of Hepato-Gastroenterology and Digestive Oncology, Hôpital Trousseau, Tours, France., Dahan L; Department of Gastroenterology and Digestive Oncology, Hôpital la Timone, Marseille, France., Ruszniewski P; Department of Gastroenterology, Hôpital Beaujon, Clichy, France., Mahamat-Abakar A; Department of Gastroenterology, Centre Hospitalier Universitaire, Nice, France., Etienne PL; Department of Medical Oncology, Hôpital Privé des Côtes d'Armor, Plerin, France., Caroli-Bosc FX; Department of Gastroenterology, Centre Hospitalier Universitaire, Angers, France., Dominguez S; Department of Digestive and Urologic Oncology, Centre Oscar Lambret, Lille, France., Paule B; Department of Gastroenterology, Hôpital Paul Brousse, Villejuif, France., Terrebonne E; Department of Hepato-Gastroenterology, Hôpital du Haut-Lévêque, Pessac, France., Michel P; Department of Hepato-Gastroenterology, Centre Hospitalier Universitaire, Rouen, France., Lepage C; Department of Hepato-Gastroenterology, Centre Hospitalier Universitaire, Dijon, France., Choukroun G; Department of Nephrology Dialysis and Transplantation, and INSERM UMR 1088, Centre Hospitalier Universitaire, Amiens, France.

مؤلفون مشاركون: for Streptotox-FFCD0906 investigators

المصدر: Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2021 Sep; Vol. 45 (5), pp. 101572. Date of Electronic Publication: 2021 Mar 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Masson Country of Publication: France NLM ID: 101553659 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-741X (Electronic) Linking ISSN: 22107401 NLM ISO Abbreviation: Clin Res Hepatol Gastroenterol Subsets: MEDLINE

مواضيع طبية MeSH: Digestive System Neoplasms*/drug therapy , Kidney*/physiology , Neuroendocrine Tumors*/drug therapy , Streptozocin*/therapeutic use, Humans ; Prospective Studies ; Retrospective Studies ; Treatment Outcome

المؤلفون: Conroy T; Institut de Cancérologie de Lorraine, Université de Lorraine, Nancy, France; APEMAC, Université de Lorraine, Nancy, France. Electronic address: t.conroy@nancy.unicancer.fr., Bosset JF; Hôpital Nord Franche-Comté, Montbéliard, France; University Hospital of Besançon, Besançon, France., Etienne PL; CARIO, Hôpital privé des côtes d'Armor, Plérin, France., Rio E; Institut de Cancérologie de l'Ouest-Site René Gauducheau, Saint-Herblain, France., François É; Centre Antoine Lacassagne, Nice, France., Mesgouez-Nebout N; Institut de Cancérologie de l'Ouest-Site Paul Papin, Angers, France., Vendrely V; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France., Artignan X; Centre Hospitalier Privé Saint-Grégoire, Saint-Grégoire, France., Bouché O; Hôpital Robert Debré, Reims, France., Gargot D; Centre Hospitalier de Blois, Blois, France., Boige V; Gustave Roussy, Villejuif, France., Bonichon-Lamichhane N; Clinique Tivoli, Bordeaux, France., Louvet C; Institut Mutualiste Montsouris, Paris, France., Morand C; Centre Hospitalier Départemental, Site de la Roche-sur-Yon, La Roche-sur-Yon, France., de la Fouchardière C; Centre Léon Bérard, Lyon, France., Lamfichekh N; Hôpital Nord Franche-Comté, Montbéliard, France., Juzyna B; R&D UNICANCER, Paris, France., Jouffroy-Zeller C; R&D UNICANCER, Paris, France., Rullier E; Centre Hospitalier et Universitaire de Bordeaux, Hôpital Haut-Lévêque, Pessac, France., Marchal F; Institut de Cancérologie de Lorraine, Université de Lorraine, Nancy, France., Gourgou S; Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France., Castan F; Institut Régional du Cancer de Montpellier, Université de Montpellier, Montpellier, France., Borg C; Hôpital Nord Franche-Comté, Montbéliard, France; University Hospital of Besançon, Besançon, France.

مؤلفون مشاركون: Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group

المصدر: The Lancet. Oncology [Lancet Oncol] 2021 May; Vol. 22 (5), pp. 702-715. Date of Electronic Publication: 2021 Apr 13.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Chemoradiotherapy*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Rectal Neoplasms/*therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Female ; Fluorouracil/adverse effects ; Fluorouracil/therapeutic use ; Humans ; Irinotecan/adverse effects ; Irinotecan/therapeutic use ; Leucovorin/adverse effects ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Neoadjuvant Therapy ; Oxaliplatin/adverse effects ; Oxaliplatin/therapeutic use ; Quality of Life ; Rectal Neoplasms/mortality ; Rectal Neoplasms/psychology